Press centre News Коммерческая практика

10
September
2018

Corn traders and oil producers prove the environmental friendliness of their operations

The major Rostov companies operating in the ports of Rostov started to execute environmental impact statements for their operations and conduct public discussions of the materials of the Environmental Impact Assessment Study. 

Dmitriy Motorin, Senior Associate
Gorod N
23
October
2017

Will SPIC's shield their parties from new price setting methods? It is an open-ended question

As the week draws to a close, an event occurred that the pharmaceutical industry had been waiting for in the course of more than one year. The Russian Ministry of Industry and Trade signed special investment contracts (SPIC's) with the Russian divisions of AstraZeneca and Sanofi. It should be that since the contracts are signed, this means that all issues have been resolved - but it meant nothing of the sort.
Сollective of authors, VEGAS LEX
Pharmaceutical Bulletin
9
August
2017

The Supreme Court set restrictions on antimonopoly control over procurement

The Supreme Court explained why it ruled that Alrosa was right in its dispute with the antimonopoly authorities. The company was looking for a contractor that would build a motor vehicle road for it up to an oilfield in northern Siberia, and during the procurement process it put forth a series of requirements for the contractor: it banned any subcontracting, and required a bank guarantee issued by a bank of its choice. The authorities decided that these conditions were unlawful because they restricted the number of participants in the procurement process. However, the Supreme Court arrived at the opposite opinion. The explanations it gave might be heartening for lawyers working for companies acting in the capacity of customers.
Pravo.ru
11
May
2017

The Federation Antimonopoly Service named those pharmaceutical companies whose drugs occupy a dominant market position

The Federal Antimonopoly Service (FAS) named 16 medicinal products that occupy more than 50% of their respective product markets. This data was derived after analyzing the state of competition in the product markets for several medicinal products, and published on the official FAS web portal.
Pharmaceutical Bulletin
26
April
2017

Flexible body

In recent years, analysts have noted an increase in the scope of public procurement for cancer drugs. Another trend is an increase in the share of drugs purchased during government bids within the framework of Federal Law No. 223. Some experts suggest that this may be due to an intensification of activity by medical clinics’ medical commissions to justify their decisions to purchase specific medicinal products.
Pharmaceutical Bulletin
10
April
2017

Expert: the question of whether to make changes to the Drug Master File because of labeling that was applied is still up in the air

Participants in the drug labeling experiment are not changing the packaging layout, but are applying a two-dimensional bar code where there is free space on the end of the package.
Pharmaceutical Bulletin
21
March
2017

Expert: "The transfer of powers to the Finance Ministry appears to be a logical measure"

The Ministry of Economic Development plans to transfer public procurement oversight powers to the Finance Ministry. The latter will have oversight of all aspects of public procurement, not just the Unified Procurement Information System (UPIS).
Trading is appropriate
7
February
2017

They are discussing the possibility of registering pharmaceutical drugs simultaneously with active pharmaceutical ingredients

A bill has been introduced in the State Duma that speeds up the process of registering medicines with the government. The bill provides for changes that present pharmaceutical companies with the opportunity to manufacture drugs from active ingredients whose master files are submitted during the pharmaceutical drug registration process. That means that generic drug manufacturers do not have to wait for around a year for active pharmaceutical ingredients to be registered, the way it was before. Market participants believe that, on the whole, the bill is good – but they have discovered legal and conceptual gaps in it.
Pharmaceutical Bulletin
10
May
2018

Letter from the governmental customer: how to recover the cost of works that are not stipulated in contract

The contractor, which renovated a children’s sports school, received a letter from the authorities requesting it to derogate from the provisions of a government contract. “Fixed windows did not allow ventilation of a hall, therefore, bottom-hinged sashes are required”, - the customer explained. The contractor did so but the counterparty then refused to pay for these works. Two instances have agreed with the latter since no supplementary agreement for installation of sashes has been signed. The court of cassation has made things right.
Pravo.ru
5
October
2017

The Law Commission on Import Substitution will supervise heavy vehicle procurement under Federal Law 223

State-run companies will have to coordinate the work they perform related to procuring watercraft and aircraft with the Law Commission on Import Substitution. The relevant changes will be made to the amendments to be introduced into Federal Law 223 in the near future. Before October 12th, agency departments will not have to heed the regulation on coordinating procurement work with the Commission – but only in the framework of investment projects. Experts talked about whether this means that state-run companies will be obligated to coordinate all procurement activity, and what, in this case, is meant by the term investment project.
Trading is appropriate
17
May
2017

Methods for ensuring that obligations are performed

When signing an agreement, the creditor will often want "insurance" in case the debtor refuses to fulfill its obligations. In this article, we will talk about the pros and cons of the various methods for ensuring that obligations are performed.
Financial Director
11
May
2017

The FAS imposed fines on pharmaceutical companies for using the word “quickly” in advertising

After reviewing a number of cases involving administrative offenses, on May 4th the Federal Antimonopoly Service ordered that the companies Astellas Pharma Europe B.V, Sandoz CJSC, and Valeant LLC pay fines for inaccurately advertising medicinal products.
Pharmaceutical Bulletin
26
April
2017

Salvation for advertisers

The number of offenses committed in the area of advertising OTC drugs has increased significantly recently. The Federal Antimonopoly Service (FAS) explains that they are concerned about the situation, and urge pharmaceutical companies to be more careful during their advertising activities. The pharmaceutical industry, in turn, fearing the initiation of more administrative liability cases, is requesting a clearer description of what they can and cannot do. However, the FAS is not agreeing to impose additional regulations.
Pharmaceutical Bulletin
6
April
2017

The Ministry of Finance drafted a bill about allowing insurance companies access to medically confidential information

The Ministry of Finance drafted amendments to the law entitled “On the organization of the insurance business in the Russian Federation”, and pursuant to them insurance companies are granted access to information about individuals that is covered by physician-patient privilege. About one year ago, there was a similar initiative that was not able to rise up to the level of interagency debate. This time, the Central Bank supports the amendments, and the Ministry of Finance has sent the draft to different agencies so that they can receive their comments before April 10th.
Medicinskiy vestnik (Medical bulletin)
17
March
2017

Work with concessions made easier for health facilities

The Russian government has approved a bill drawn up by the Ministry of Healthcare aimed at expanding the usage of concession agreements with regard to healthcare facilities. The draft law, which amends Sections 5 and 8 of the Federal Law "On Concession Agreements", will soon be put to the State Duma.
Medicinskiy vestnik (Medical bulletin)
31
January
2017

Putin instructed that prices be reviewed for essential medicines

The President instructed the government to review the prices for essential medicines, and to check all public procurement of medicinal products. The head of state demanded clarification on whether the cost of medicinal drugs has been inflated.
RBC
Pages: 1 2 3 4 Next

Apply to participate

Agreement

Apply to participate

Оценка:

Agreement
By continuing to use this site, you consent to the VEGAS-LEX Law Firm, Moscow, to the processing of cookies and relevant user data (IP address, location information, OS type and version, browser type and version, device type and screen resolution, source of access to the site, operating system and browser language, behavior on the site) for the purpose of functioning of the site, conducting statistical research and web analytics, including using third-party services. If you do not want your data to be processed, change the appropriate settings of your browser or leave the site.
More info Accept